Report : Asia Pacific Gastric Buttons Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Offerings (Products and Accessories), Application (Children and Adults), Usage (Enteral Nutrition, Medications, Fluids, and Others), and End User (Hospitals, Clinics, and Others)
At 8.0% CAGR, the Asia Pacific Gastric Buttons Market is speculated to be worth US$ 93.42 million by 2028, says Business Market Insights
According to Business Market Insights’ research, the Asia Pacific gastric buttons market was valued at US$ 58.71 million in 2022 and is expected to reach US$ 93.42 million by 2028, registering a CAGR of 8.0% from 2022 to 2028. Collective prevalence of cancer, neurological disorders, diabetes, and gastrointestinal diseases and expanding geriatric population are the critical factors attributed to the Asia Pacific gastric buttons market expansion.
Diabetes is a life-threatening chronic disease with no functional cure. Diabetes can lead to various complications in different body parts and increase the overall risk of premature death. Heart attack, stroke, kidney failure, leg amputation, vision loss, and nerve damage are the major complications associated with diabetes.
Maintaining proper nutrition during cancer treatment is essential. When cancer patients struggle with nutrition, gastric buttons can help provide vitamins, minerals, calories, protein, and fluids required to help the patient fight infection, heal, and stay healthy during cancer treatment.
Neurological disorders such as Parkinson's disease, dementia, epilepsy and seizures, autism, cerebral palsy, and Alzheimer's disease affect the brain and nerves of the human body. Weight loss and malnutrition as suboptimal oral intake are common in patients with neurological disorders and are associated with increased disability, morbidity, and mortality.
Epilepsy is a noncommunicable chronic brain disease that affects people of all ages. Almost 80% of people with epilepsy live in low- and middle-income countries. The same source estimates that up to 70% of people with epilepsy could live seizure-free with proper diagnosis and treatment. The nutritional management of patients with neurological disease is crucial, and enteral feeding is a commonly used method to provide nutritional support.
A gastrointestinal disease affects the gastrointestinal (GI) tract, the passage that runs from the mouth to the anus. Common GI disorders include irritable bowel syndrome (IBS), acid reflux, indigestion, colon cancer, and hemorrhoids. According to the data published by International Foundation for Gastrointestinal Disorders, among all irritable bowel syndrome patients, ~40% of people have mild IBS, ~35% have moderate IBS, and ~25% have severe IBS. Certain factors such as food allergies, developing stages of gastroenteritis, sporadic colon movements, the abnormal composition of serotonin in the colon, and mild celiac disease are among the risk factors that cause irritable bowel syndrome. Pancreatic diseases, liver diseases, and inflammatory bowel diseases (IBDs) are often associated with nutritional difficulties and require adequate nutrition to support medical treatment.
The gastrostomy button has recently been used as the enteral route of choice by many doctors and has the cosmetic advantage of being hidden under clothing. Once placed, it can be used for several days.
As chronic diseases are increasing faster, the adoption of the gastrostomy button for administration of food and medicine has been progressing rapidly over the last five years, which is driving the Asia Pacific gastric buttons market.
On the contrary, problems associated with gastric buttons hurdles the growth of Asia Pacific gastric buttons market.
Based on offerings, the Asia Pacific gastric buttons market is bifurcated into products and accessories. The products segment held 59.7% market share in 2022, amassing US$ 35.08 million. It is projected to garner US$ 57.46 million by 2028 to expand at 8.6% CAGR during 2022–2028. Further, accessories are segmented into button feeding sets, button decompression sets, and others.
Based on application, the Asia Pacific gastric buttons market is bifurcated into children and adults. The children molding segment held 61.5% market share in 2022, amassing US$ 36.08 million. It is projected to garner US$ 59.40 million by 2028 to expand at 8.7% CAGR during 2022–2028.
Based on usage, the Asia Pacific gastric buttons market is categorized into enteral nutrition, medications, fluids, and others. The enteral nutrition molding segment held 45.4% share of Asia Pacific gastric buttons market in 2022, amassing US$ 26.65 million. It is projected to garner US$ 43.92 million by 2028 to expand at 8.7% CAGR during 2022–2028.
Based on end user, the Asia Pacific gastric buttons market is categorized into hospitals, clinics, and others. The hospitals molding segment held 54.8% share of Asia Pacific gastric buttons market in 2022, amassing US$ 32.19 million. It is projected to garner US$ 53.04 million by 2028 to expand at 8.7% CAGR during 2022–2028.
Based on country, the Asia Pacific gastric buttons market has been categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. Our regional analysis states that China captured 27.6% market share in 2022. It was assessed at US$ 16.21 million in 2022 and is likely to hit US$ 27.18 million by 2028, exhibiting a CAGR of 9.0% during the forecast period.
Key players dominating the Asia Pacific gastric buttons market are Avanos Medical Inc., Boston Scientific Corp, QMD, Shin-Etsu Polymer Europe BV, Vygon (UK) Ltd, and Fresenius Kabi AG among others.
Contact Person: Sameer Joshi
Phone: +1- 646- 491- 9876
Email id: firstname.lastname@example.org